First-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Dual Immunotherapy Combined With Chemotherapy
Clinical trial NCT07400315 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07400315
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2028-12-31
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.